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Human embryonic stem (ES) cells oﬀ  er  tremendous 
opportunities for regenerative medicine, because they are 
capable of indeﬁ   nite self-propagation and of diﬀ  eren-
tiating into any cell types of three germ layers [1]. Signi-
ﬁ   cant progress has been made in understanding the 
maintenance of ES cells, and now induced pluripotent 
stem cells can be generated from most (if not all) somatic 
cells with the deﬁ  ned transcription factors c-MYC, KLF4, 
SOX2 and OCT4 [2] and/or small molecules [3]. A better 
understanding of how to derive speciﬁ  c cell types from 
stem cells will increase the rate of translation of basic 
laboratory work to the clinic for patient-tailored therapy.
Neural induction in embryos and ES cells
Formation of the central nervous system has drawn the 
attention of developmental biologists for almost a century 
since Spemann and Mangold discovered that the dorsal lip 
of the blastopore was capable of inducing neural diﬀ  er-
entiation in Xenopus gastrula [4]. A list of Spemann 
organizers has been identiﬁ   ed that to date includes 
Noggin, Gremlin, Cerberus, Twisted Gastrulation and 
Chordin. Th  ey are secreted molecules that directly bind 
and antagonize bone morphogenetic proteins (BMPs) 
[5,6].
BMPs bind/activate speciﬁ  c  high-aﬃ     nity type I and 
type II Ser/Th  r kinase receptors, including ALK1 to 
ALK7, ActRII, ActRIIB, TβRII, BMPRI and BMPRII, and 
signal through the canonical SMAD pathways. BMP 
signaling pathways are present in ES cells and readily 
inhibit neural diﬀ  er  entiation. When BMP inhibition is 
removed, the majority of surviving cells diﬀ  erentiate into 
neurons. Neural induction is therefore considered a 
default process that takes place autonomously and 
intrinsically [5]. Little is known, however, about the 
intracellular factors involved.
Kamiya and colleagues now report in Nature, with 
compelling evidence, that a zinc ﬁ   nger (ZF) nuclear 
protein, Zfp521, is a key intrinsic molecule capable of 
directing ES cells to neural progenitors [7]. Th  ey ﬁ  rst 
knocked-in a GFP reporter gene into a neural precursor 
locus Sox1 and cultured embryoid bodies for 3 days of 
default neural diﬀ  erentiation.  Th  ey separated green 
(neural) and nongreen cells by ﬂ   ow cytometry, and 
identi ﬁ  ed 104 genes that were expressed highly in GFP-
positive cells but were low in non-GFP cells. One of these 
genes, Zfp521, was able to turn ES cells into Sox1-GFP-
positive neural progenitors by overexpression, either in 
the presence of BMPs or 10% FCS, which would normally 
inhibit neural diﬀ  erentiation.
Next, Zfp521 was shown to directly activate early neural 
genes such as Sox1,  Sox3 and N-cadherin by working 
together with the co-activator p300. Knockdown of 
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markers Rex1 and Nanog, but halted cells at the epiblast 
stage with sustained epiblast marker gene expression 
including  Oct4,  Cripto and Fgf5. Meanwhile Zfp521 
depletion suppressed early neural gene induction and 
neural diﬀ   erentiation. Zfp521 is therefore critical for 
epiblast–neuroectoderm transition (Figure 1a) [7].
Zfp521 structural domains and binding partners
Zfp521 is a nuclear protein with a putative nuclear locali-
zation signal (seven amino acids) immediately upstream 
of ZF9. Th  e protein contains 30 Krüppel-like ZF motifs 
clustered in ﬁ   ve to seven ZFs throughout the protein 
(Figure 1b), interacts with multiple partners (Figure 1c), 
and regulates transcription in diverse tissues and organs. 
In ES cells, Zfp521 associates with p300 through ZF1 to 
ZF8 at the N-terminus to activate early neural genes and 
trigger neural diﬀ  erentiation [7]. In the hematopoietic 
system, its human counterpart ZNF521 binds and 
inhibits GATA-1 via ZF21 to ZF26, and this maintains 
the stemness of hematopoietic progenitors and represses 
erythroid diﬀ   erentiation [8]. Depletion of ZNF521 by 
shRNA can transform K562 and HEL cells into erythroid 
cells synthesizing hemoglobin and glyco  phorin A. Th  e  C-
terminus of ZNF521 is also required for interaction/
inhibition of OLF1/EBF1  , and the latter is important for 
activating B-cell-speciﬁ  c gene expression [9] and for the 
development of striatal medium spiny neurons [10]. 
Zfp521 also associates and attenuates RunX2 via ZF6 to 
ZF26 [11,12], and regulates two stages of osteoblast 
develop  ment during mesenchymal cell lineage commit-
ment and during osteoblast maturation [12,13].
Additionally, Zfp521 is capable of implementing epi-
genetic eﬀ  ects through global remodeling of the nucleus. 
Th   is is achieved via a 12-amino-acid motif called nuclear 
remodeling and histone deacetylation complex (NuRD) 
at its N-terminal end, which binds histone deacetylases 
(HDACs) [14]. Th  e general view is that HDACs de-
acetylate histones and repress gene transcription. For 
example, ZNF521 inhibits GATA-1 through NuRD, and 
deletion of the motif results in reduction of the inhibitory 
eﬀ  ect in hematopoietic progenitors [8]. Th   e NuRD motif 
is highly conserved among other ZF transcription factors, 
including ZNF423, Friend of GATA (FOG-1/ZFPM1 and 
FOG-2/  ZFPM2), BCL11A, and SALL family members 
[14], and may recruit diﬀ  erent HDACs in diﬀ  erent cells. 
In chondrocytes, Zfp521 forms a complex with HDAC3/
HDAC4 and inhibits RunX2 activity [11,12]. In ES cells 
Zfp521 antagonizes HDAC1/HDAC3, which inhibit 
p300-induced neural diﬀ   erentiation. Whether Zfp521, 
HDACs and p300 form one complex, however, is unclear. 
One scenario can be that association of p300 and Zfp521 
results in either inactivation or release of HDACs from 
the complex.
Figure 1. Zfp521 structure and function. (a) In mouse embryonic stem (ES) cells, Zfp521 is essential for directing epiblasts to neuroectoderm 
cells, which is inhibited by bone morphogenetic protein (BMP) signaling pathways. (b) Schematic presentation of the Zfp521 protein, which 
contains a nuclear remodeling and histone deacetylation complex (NuRD) motif () at the N-terminal end, 30 C2H2 zinc fi  ngers (ZF1 to ZF30, ) 
throughout the protein, and a putative nuclear localization signal (▲) between ZF8 and ZF9. (c) Zfp521 recruits histone deacetylase (HDAC1/
HDAC3/HDAC4) through the NuRD motif, associates with co-activator p300 via ZF1 to ZF8, and inhibits GATA-1 and EBF1 by the C-terminal regions, 
and binds RunX2 through ZF6 to ZF26. LIF, leukemia inhibitory factor.
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isoform is predicted in human (uc002kvl.2) and rat 
(NP_001100873), which lacks the ﬁ  rst 220 amino acids 
including the NuRD motif and ZF1 to ZF5. Meanwhile, the 
NuRD domain is neither required for the activation of N-
cadherin expression in ES cells [7] nor for the inhibition of 
EBF1 in the hemato  poietic system [9]. Infor  ma  tion 
remaining to be validated includes whether the short 
isoform exists or is conserved during evolution, whether 
Zfp521 isoforms are expressed in diﬀ  erent tissues, and 
whether the NuRD-truncated form is constitutively active 
as a result of its incapability to bind HDACs or is dominant 
negative as a result of missing ZF1 to ZF5.
Zfp521 expression and regulation
As a key intrinsic factor driving neural determination, we 
expect that Xenopus xZfp521 would be expressed at the 
early gastrula stage, such as st10.5, when neural induction 
is initiated by the Spemann organizer. Surprisingly, 
xZfp521 mRNA was not detected at st10.5 by in situ 
hybridization [7]. In mouse embryos, Zfp521 transcripts 
were not detected in blastocysts as anticipated, but were 
expressed weakly in E6.5 and strongly in E7.0 neuro-
ectoderm during gastrulation. Whether Zfp521 is ex-
pressed in early postimplantation mouse embryos (E3.5 
to E6.5) remains to be seen. Forced Zfp521 expression 
could not drive neural diﬀ  erentiation in the presence of 
leukemia inhibitory factor or the ﬁ  broblast growth factor 
receptor inhibitor SU5402, suggesting that Zfp521 may 
be a key factor for sustaining rather than initiating neural 
diﬀ  erentiation.
Understanding how Zfp521 is regulated is equally 
important. In ES cells it is currently unknown whether 
Zfp521 expression is purely repressed by BMP signaling, 
or can be induced by any other factors. What is known is 
that Zfp521 expression in chondrocytes can be increased 
by parathyroid hormone-related peptide (PTHrP) signal-
ing or elevated adenylyl cyclase activity [11]. Knock-in of 
a GFP reporter into the Zfp521 locus of ES cells with a 
similar approach may indicate whether any of the 104 
genes highly expressed in Sox1-GFP cells is upstream of 
the Zfp521. Alternatively, a quantitative RT-PCR analysis 
of the genes in a time course of the 3-day neural 
induction could indicate whether any factor was induced 
prior to Zfp521. It will also be interesting to know 
whether WNT signaling pathways [15], downstream of 
the adenylyl cyclase pathway such as protein kinase A, or 
a well-known neural inducer such as retinoic acid may 
inﬂ  uence Zfp521 expression.
Zfp521 function
Zfp521 is expressed in a wide range of tissues including 
the brain, muscle, heart, kidney, spleen, lymph nodes, 
placenta, thymus and fetal liver [16]; in particular, in 
immature cells such as early mesenchymal condensations, 
developing bones, hematopoietic stem cells, and neural 
progenitors.  Zfp521 was initially called Evi3 in mouse, 
which was identiﬁ   ed as a common integration site of 
retrovirus in murine AKXD B-cell lymphomas [17]. Th  e 
virus integrates upstream of the ﬁ  rst coding exon, which 
results in upregulation of Evi3. Th   e human ZNF521 was 
previously termed early hematopoietic zinc ﬁ  nger 
protein, and its expression in the hematopoietic system 
was restricted to a subpopulation of less diﬀ  erentiated 
CD34+ cells. ZNF521 is abundant in leukemia, medullo-
blastomas and other brain tumors. iRNA-mediated 
ZNF521 silencing impairs the growth and clonogeneity 
of MLL+/ZNF521+ THP-1 cells. High levels of Zfp521 
expression may therefore be associated with oncogenesis.
Zfp521 is shown to regulate a number of cellular 
processes. Th  e protein promotes proliferation, delays 
diﬀ  er  entiation and reduces apoptosis [13]. In cultured 
mesenchymal cells, Zfp521 expression is decreased by 
BMP2 and increased by PTHrP, which promote and 
antagonize osteoblast diﬀ  erentiation,  respectively. 
Deleting  Zfp521 also decreases cyclin D1 and Bcl-2 
expression with increased caspase-3 activation and 
apoptosis. Interest  ingly, in stage 15 of Xenopus embryos 
developed from injection of xZfp521 expression vector at 
the eight-cell stage, an altered distribution pattern of cells 
expressing pro-neural markers Neurogenin and Estrogen 
Receptor 1 is observed [7]. Th   is observation suggests that 
Zfp521 overexpression may induce ectopic expression of 
pro-neural genes. Alter  natively, appropriate levels of 
Zfp521 expression may be essential for neuronal migra-
tion. Zfp521 expres  sion in adult brain is very limited, 
however, based on the Allen Brain Atlas [18] in 
comparison with developing neural tubes [7], whereas 
relatively high levels of the mRNAs for Zfp521 and its 
partner Ebf1 are detected in striatonigral neurons of the 
adult mouse [10] – Zfp521 may therefore be involved in 
neurodegenerative and psychiatric disorders.
In summary, Zfp521 plays important roles in multiple 
tissues. Zfp521 mediates PTHrP signaling, and regulates 
proliferation and diﬀ  erentiation of growth plate chondro-
cyte [11] and bone formation [13]. In embryos, Zfp521 is 
critical for rostral neural tube development, because 
Zfp521-depleted ES cells fail to contribute to the rostral 
neural tube, although they are found in other parts of 
chimeric embryos [7]. Investigation of Zfp521–/– mice 
will reveal how Zfp521 aﬀ  ects brain development. Th  e 
excellent work carried out by Kamiya and colleagues 
demonstrates that Zfp521 is a key factor to sustain neural 
diﬀ  erentiation. Th  ese ﬁ  ndings have opened up a whole 
series of studies to investigate how Zfp521 works 
together with other transcriptional factors and epigenetic 
factors to regulate neural diﬀ  erentiation in stem cells and 
in developing brains of mice and men.
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